Diabetes Board decisions

The Board granted service connection for obstructive sleep apnea as secondary to the Veteran's service-connected lumbosacral spine disability, but denied service connection and higher ratings for hypertension, diabetes mellitus, type II, GERD, cervical strain with degenerative joint disease and IVDS, right upper extremity radiculopathy, and left upper extremity radiculopathy.

The Board remands the claims for a compensable rating for healed stress fracture, left third metatarsal base with neurapraxia of left anterior tibial nerve and service connection for chronic anxiety, chronic depression, diabetes, and sleep apnea due to insufficient evidence.

The Board remands the claims for service connection for a psychiatric disorder, tinnitus, bilateral hearing loss, and diabetes mellitus to allow for further development of the evidence.

The appeal for service connection for diabetes mellitus was withdrawn and dismissed, while the claim for a kidney disability is remanded for further development.

The Board granted service connection for heart disease and diabetes mellitus, both presumed to be related to herbicide exposure during the Veteran's service in Korea. However, it denied service connection for memory problems to include dementia, left foot fungal infection disability, right foot fungal infection disability, left leg disability, and right leg disability.

The Board dismissed the appeals for service connection for PTSD, diabetic retinopathy, sleep apnea, and diabetes mellitus as they were improperly filed or not properly before the Board.

The Board granted a 30 percent rating for irritable bowel syndrome (IBS) with gastroesophageal reflux disease (GERD), effective February 1, 2023.

The Veteran withdrew the appeal for all claims, including those related to service-connected hearing loss, diabetes mellitus, and diabetic peripheral neuropathy.

The Board remands the claims for service connection for coronary artery disease and type II diabetes to address whether a toxic exposure risk activity examination is warranted under the PACT Act.

The Board granted service connection for bilateral foot, cervical spine, and bilateral hip disabilities but denied service connection for an eye disability, OSA, a sinus disability, and a nail condition. The Board also denied an increased rating for hearing loss and dismissed the TDIU claim.

The Board granted earlier effective dates for the award of service connection for diabetes, CAD, and bilateral lower extremity diabetic peripheral neuropathy.

The Board granted the appeal to reinstate service connection for type II diabetes mellitus, finding that the severance was not proper.

The Board granted earlier effective dates of May 19, 2011 for service connection for CAD, diabetes mellitus type II, and hypertension based on the Veteran's presumed exposure to herbicide agents during his service in Thailand.

The Board remands the claims for service connection for type II diabetes, hypertension, and bilateral hearing loss for readjudication with new evidence.

The Board granted service connection for diabetes mellitus, type 2 and ischemic heart disease beginning August 10, 2022, under the PACT Act. The claims for these conditions prior to that date were remanded.

The Board remands the claims for service connection for obstructive sleep apnea, hypertension, hypertensive chronic kidney disease, diabetes mellitus, Type II, and cardiomyopathy as they are inextricably intertwined with each other.

The Board granted a 10 percent rating for hypertension but denied an increased rating in excess of 80 percent for diabetic nephropathy.

The Board granted service connection for the cause of the Veteran's death, finding that the service-connected disabilities contributed substantially to the cause of death by coronary artery disease, hypertension, and diabetes.

The Board denied the Veteran's appeal for a higher rating for tinnitus, as it is already rated at 10 percent, which is the maximum allowed. The other issues are remanded for further development.

The Board granted service connection for multiple conditions, including diabetes mellitus, type II, coronary artery disease, and various neuropathies and disabilities, effective September 30, 2010, for accrued benefits purposes.